Workflow
Genetic Engineering
icon
Search documents
Is CRISPR Therapeutics (CRSP) a Buy as Wall Street Analysts Look Optimistic?
ZACKS· 2025-06-27 14:31
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about CRISPR Therapeutics AG (CRSP) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.CRISPR Therapeutics currently has an average brok ...
新型基因编辑工具精准嵌入完整基因
news flash· 2025-05-20 22:07
智通财经5月21日电,美国麻省理工学院与哈佛大学博德研究所刘如谦团队联合哥伦比亚大学科学家, 成功研发出新型基因编辑工具evoCAST。这款工具能像编程般精准地将完整基因或多个基因嵌入人类基 因组特定位置,为遗传疾病治疗带来突破性进展。相关成果发表于最新一期《科学》杂志。 新型基因编辑工具精准嵌入完整基因 ...
Twist Bioscience: Expansion Efforts Continue To Face Challenges
Seeking Alpha· 2025-05-07 06:18
Twist Bioscience (NASDAQ: TWST ) reported solid results in the second quarter of FY2025, but the management team appeared downbeat on the earnings call. Twist has also chosen to spin out its data storage segment, with a fairly modest value attached to the business. TheRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess risk adjusted returns can be achie ...